欧洲皮肤病论坛S1指南:皮肤硬化性疾病诊断与治疗第一部分
该指南由欧洲皮肤病论坛制定,聚焦局限性硬皮病(莫菲亚)、系统性硬化症及重叠综合征。指南详述临床与组织病理特征、诊断评分及血清自身抗体用于鉴别诊断,并阐述一线和进阶治疗策略。
要点
- 皮肤硬化性疾病包括局限性硬皮病和系统性硬化症等,需结合临床与病理鉴别。
- 血清自身抗体和诊断评分有助于区分不同硬化性疾病亚型。
- 指南提供一线及进阶治疗方案,指导临床分层治疗。
核心结论
- 指南为局限性硬皮病、系统性硬化症及重叠综合征提供诊断与治疗框架。
研究设计与样本
- 欧洲皮肤病论坛制定的S1指南,基于专家共识总结诊断与治疗建议。
主要发现
- 皮肤硬化性疾病按皮肤和皮肤外受累分为不同临床亚型,有时难以相互区分。
关键数值与推荐
- 指南强调特征性临床与组织病理特征、诊断评分及最有用血清自身抗体用于鉴别诊断。
- 指南详述一线和进阶治疗策略。
临床怎么用
- 临床医生可依据指南识别疾病亚型,并选择一线或进阶治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.
引用
- Knobler R, Moinzadeh P, Hunzelmann N, et al. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol. 2017. PMID: 28792092. doi:10.1111/jdv.14458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。